About
MEI Pharma, Inc. is a pharmaceutical company with a portfolio of several drug candidates that may offer novel and differentiated cancer therapies. The drug candidate pipeline includes voruciclib, an oral cyclin-dependent kinase 9 inhibitor.
Sector context
Trading at a discount to sector peers
Lower quality - review fundamentals carefully
Small-cap company with higher volatility
Similar companies